Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2020-06-29

Original market date: See footnote 1

1976-12-31

Product name:

3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE

DIN:

00038881 Electronic product monograph is not available

Company: 

ICU MEDICAL CANADA INC
2600 Boul Alfred-Nobel, Suite 100
Saint Laurent
Quebec
Canada  H4S 0A9

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

2

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:20.00   CALORIC AGENTS ,  40:12.00   REPLACEMENT PREPARATIONS

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BB02  ELECTROLYTES WITH CARBOHYDRATES

Active ingredient group (AIG) number:See footnote 5

0200203006

List of active ingredient(s)
Active ingredient(s) Strength
DEXTROSE 33.3 MG / ML
SODIUM CHLORIDE 3 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: